Neurocept

Neurocept is a specialized biotechnology and medical device company focused on the localized delivery of therapeutic agents to the central nervous system. The company's core technology is the Neurocept Catheter System, which utilizes convection-enhanced delivery (CED) to bypass the blood-brain barrier and deliver drugs directly into brain tissue. This platform is primarily targeted at treating glioblastoma multiforme and other aggressive brain tumors by enabling high local concentrations of chemotherapy while minimizing systemic toxicity. Neurocept's approach aims to improve the efficacy of existing and novel therapeutic agents that are otherwise limited by poor CNS penetration.